Group name
Total
T0
2 (2.2%)
T2
58 (63.7%)
T3
30 (35.2%)
T4
1 (1.1%)
remark
Pathological stage,n (%)
GS 2-6
7 (7.9%)
GS 7
66 (74.2%)
GS 8-10
16 (18.0%)
Pathological GS,n (%)